Explore how medical science battles EGFR resistance mutations in non-small cell lung cancer through innovative drug development and targeted therapies.
Exploring how 1,3,4-triazaphenalene and 1,3,4,6-tetraazaphenalene derivatives target EGFR tyrosine kinase in cancer treatment